Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorToprak, Ömer
dc.contributor.authorTuran, Ömer Faruk
dc.contributor.authorBozyel, Emel Aslan
dc.contributor.authorAlp, Burak
dc.contributor.authorUçdu, Gülhan Zorgör
dc.date.accessioned2022-03-10T07:38:43Z
dc.date.available2022-03-10T07:38:43Z
dc.date.issued2021en_US
dc.identifier.issn1398-2273 -1399-3062
dc.identifier.urihttps://doi.org/10.1111/tid.13578
dc.identifier.urihttps://hdl.handle.net/20.500.12462/12096
dc.description.abstractTo the Editor, Herpes zoster (HZ) is a cutaneous viral infection caused by the reactivation of latent varicella-zoster virus (VZV) in the dorsal root ganglia.1 Immunosuppressed patients, kidney transplant recipients, and chronic kidney disease (CKD) patients are at high risk for de-veloping HZ infection.2,3 The typical clinical manifestation of HZ is an acute unilateral eruption of herpetiform vesicles in a localized dermatomal area associated with pain.4 However, two to five days before the rash, in prodromal phase, there may be only local neuro-pathic pain in the affected dermatome.en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.relation.isversionof10.1111/tid.13578en_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectAcute Kidney Injuryen_US
dc.subjectHerpes Zosteren_US
dc.subjectKidney Transplantationen_US
dc.subjectProdromal Phaseen_US
dc.titleDialysis-requiring acute kidney injury and electrolyte imbalances as a result of prodromal herpes zoster in a kidney transplant recipienten_US
dc.typeletteren_US
dc.relation.journalTransplant Infectious Diseaseen_US
dc.contributor.departmentTıp Fakültesien_US
dc.contributor.authorID0000-0002-2865-1687en_US
dc.identifier.volumeEarly Access FEB 2021en_US
dc.identifier.startpage1en_US
dc.identifier.endpage4en_US
dc.relation.publicationcategoryDiğeren_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster